IDH3A and glioma: It should be noted that the 2016 World Health Organization (WHO) classification for glioma added the molecular subtype [isocitrate dehydrogenase (IDH) or telomerase reverse-transcriptase promoter (TERTp) mutation and 1p19q codeletion], which is highly associated with tumor invasiveness and prognosis (16, 17).